Glycopyrrolate
HealthData.Gov
Updated Mar 25, 2026
About this dataset
Glycopyrrolate is an injectable anticholinergic medication that blocks certain nerve signals to reduce secretions and treat conditions like bradycardia. Administered via intramuscular or intravenous injection at 0.2 mg/mL strength, it's available in multi-dose vials from Meitheal Pharmaceuticals Inc. (ANDA212802). This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Glycopyrrolate
Access the FDA dataset for Glycopyrrolate — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025